1 / 15

Drug Use Practices in Malaria in Cambodia: A Cross-Sectional Study

This study examines the drug use practices in malaria treatment in Cambodia, focusing on treatment-seeking behavior, availability of blood test services, and types of medications received. The findings highlight the reliance on private medical providers and the need for targeted education and training.

virginiak
Download Presentation

Drug Use Practices in Malaria in Cambodia: A Cross-Sectional Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. WHO Community drug use practices in malaria in Cambodia: a cross-sectional study National Malaria Centre of Cambodia Rational Pharmaceutical Management Plus Program World Health Organization European Commission Cambodian Malaria Control Programme Wellcome Trust Mahidol Oxford Trop. Med. Research Programme

  2. Part One The drug situation on the Cambodian-Thai border Boukheng Thavrin

  3. First treatment sought by provider type (n=1277)

  4. Percentage visiting government facilities for treatment

  5. Patient Self Medication Patient requested specific drug product (according to providers) • Public Health facilities: 0% of patients • Village based private providers: 25% • 75% of patients rely on village provider recommendations • Important for targeting education and training • Market based private providers: 50%

  6. Treatment seeking for fever • 7% did not seek modern treatment • 93% sought a modern treatment by the end of the third day • 45% sought a modern treatment on the first day of illness

  7. Availability of Blood Test Services (provider report)

  8. Household antimalarial use (first treatment)

  9. 100 90 80 70 60 50 40 30 20 10 0 A+M Artekin quinine cotexcin Malarine Fansidar artesunate artemether mefloquine primaquine tetracycline chloroquine artemisinine any artemisinine Government Facility Stock

  10. Market Facility Stock

  11. Village Facility Stock

  12. First Line Treatment Received

  13. Mean cost for treatments sought • Single treatment: 3000 Riel • Two treatments: 10,000 Riel • Three treatments: 13,000 Riel • Range of single treatment costs: zero to 552,500 Riel (US$138)

  14. Summary • Persons with fever seek treatment within 3 days of symptoms • The majority of persons with fever seek private medical treatment • Village providers are an important source of treatment recommendations • When treatment is unsuccessful, patients seek care in the public sector

  15. Summary (2) • 60% of market and village providers offered no blood tests • 11% of patients received recommended pre-packaged treatments • First line treatment was available in the public sector, but was rare in other settings • Artesunate & quinine monotherapies were the most common treatments received

More Related